• Nathan Goldstein, Melissa Carlson, Elayne Livote, and Jean S Kutner.
• Mount Sinai School of Medicine, New York, New York 10029, USA. Nathan.Goldstein@mssm.edu
• Ann. Intern. Med. 2010 Mar 2;152(5):296-9.

BackgroundCommunication about the deactivation of implantable cardioverter-defibrillators (ICDs) in patients near the end of life is rare.ObjectiveTo determine whether hospices are admitting patients with ICDs, whether such patients are receiving shocks, and how hospices manage ICDs.DesignCross-sectional survey.SettingRandomly selected hospice facilities.Participants900 hospices, 414 of which responded fully.MeasurementsFrequency of admission of patients with ICDs, frequency with which patients received shocks, existence of ICD deactivation policies, and frequency of deactivation.Results97% of hospices admitted patients with ICDs, and 58% reported that in the past year, a patient had been shocked. Only 10% of hospices had a policy that addressed deactivation. On average, 42% (95% CI, 37% to 48%) of patients with ICDs had the shocking function deactivated.LimitationThe study relied on the knowledge of hospice administrators.ConclusionHospices are admitting patients with ICDs, and patients are being shocked at the end of life. Ensuring that hospices have policies in place to address deactivation may improve the care for patients with these devices. The authors provide a sample deactivation policy.Primary Funding SourceNational Institute of Aging and National Institute of Nursing Research.

12 keywords...

hide…